Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Combe

Showing results (161-170 of 282) with videos related to

Pageof 29
Sort By:
The Journal of Rheumatology|December 17, 2003
Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritisBernard Combe, Alain Cantagrel, Philippe Goupille, et al.
The Journal of Rheumatology|August 4, 2005
Use of combination of leflunomide with biological agents in treatment of rheumatoid arthritisJoachim R Kalden, Christian Antoni, Jose M Alvaro-Gracia, et al.
Rheumatology (Oxford, England)|November 14, 2019
An updated matrix to predict rapid radiographic progression of early rheumatoid arthritis patients: pooled analyses from several databasesAntoine Vanier, Josef S Smolen, Cornelia F Allaart, et al.
RMD Open|November 5, 2015
Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 studyMichael Schiff, Bernard Combe, Thomas Dörner, et al.
Annals of the Rheumatic Diseases|November 7, 2020
Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countriesChristian Dejaco, Alessia Alunno, Johannes Wj Bijlsma, et al.
Clinical Rheumatology|September 13, 2021
Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52Frank Behrens, Soyi Liu Leage, Christophe Sapin, et al.
Rheumatology (Oxford, England)|May 19, 2012
Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trialEdward C Keystone, Bernard Combe, Josef Smolen, et al.
The Journal of Rheumatology|May 3, 2006
Safety of infliximab used in combination with leflunomide or azathioprine in daily clinical practiceAleth Perdriger, Xavier Mariette, Jean-Louis Kuntz, et al.
Annals of the Rheumatic Diseases|November 27, 2012
The TNF family member APRIL dampens collagen-induced arthritisLeticia Fernandez, Gabriela Franco Salinas, Cecilia Rocha, et al.
Rheumatology (Oxford, England)|May 9, 2009
Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 casesClaire Immediato Daïen, Agnes Monnier, Pascal Claudepierre, et al.
Pageof 29

Showing results (161-170 of 282) with videos related to

Sort By:
Pageof 29
The Journal of Rheumatology|December 17, 2003
Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritisBernard Combe, Alain Cantagrel, Philippe Goupille, et al.
The Journal of Rheumatology|August 4, 2005
Use of combination of leflunomide with biological agents in treatment of rheumatoid arthritisJoachim R Kalden, Christian Antoni, Jose M Alvaro-Gracia, et al.
Rheumatology (Oxford, England)|November 14, 2019
An updated matrix to predict rapid radiographic progression of early rheumatoid arthritis patients: pooled analyses from several databasesAntoine Vanier, Josef S Smolen, Cornelia F Allaart, et al.
RMD Open|November 5, 2015
Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 studyMichael Schiff, Bernard Combe, Thomas Dörner, et al.
Annals of the Rheumatic Diseases|November 7, 2020
Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countriesChristian Dejaco, Alessia Alunno, Johannes Wj Bijlsma, et al.
Clinical Rheumatology|September 13, 2021
Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52Frank Behrens, Soyi Liu Leage, Christophe Sapin, et al.
Rheumatology (Oxford, England)|May 19, 2012
Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trialEdward C Keystone, Bernard Combe, Josef Smolen, et al.
The Journal of Rheumatology|May 3, 2006
Safety of infliximab used in combination with leflunomide or azathioprine in daily clinical practiceAleth Perdriger, Xavier Mariette, Jean-Louis Kuntz, et al.
Annals of the Rheumatic Diseases|November 27, 2012
The TNF family member APRIL dampens collagen-induced arthritisLeticia Fernandez, Gabriela Franco Salinas, Cecilia Rocha, et al.
Rheumatology (Oxford, England)|May 9, 2009
Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 casesClaire Immediato Daïen, Agnes Monnier, Pascal Claudepierre, et al.
Pageof 29